Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
Background: All-oral regimens, including bedaquiline, are now standard in shorter treatment regimens (STRs) for multidrug-resistant tuberculosis (MDR-TB). Resistance or intolerance to drugs in STR often necessitates a switch to longer treatment regimens (LTRs). This study aims to identify the factor...
Saved in:
Main Authors: | Oki Nugraha Putra, Nur Indah, Telly Purnamasari, Adi Larasanti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | International Journal of Mycobacteriology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ijmy.ijmy_164_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and Effectiveness of BPaL-Based Regimens to Treat Multidrug-Resistant TB: First Experience of an Italian Tuberculosis Referral Hospital
by: Gina Gualano, et al.
Published: (2024-12-01) -
Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region
by: G.B. Migliori, et al.
Published: (2024-03-01) -
Treating drug-resistant tuberculosis in an era of shorter regimens: Insights from rural South Africa
by: J-D K Lotz, et al.
Published: (2023-11-01) -
Savings from the introduction of BPaL and BPaLM regimens at the country level
by: C. Auer, et al.
Published: (2024-07-01) -
How Does Heavy Precipitation of Varying Durations Respond to Urbanization in China?
by: Xue Xie, et al.
Published: (2024-07-01)